Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
  1. 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 17,395 shares (to pay taxes)
  3. 4 Shares withheld for taxes CEO gave up 20,840 shares (to pay taxes)
  4. 4 Shares withheld for taxes CEO gave up 782 shares (to pay taxes)
  5. 4 Open-market buy Chief Medical Officer bought 22,123 shares at $1.17 ($25,884)
  6. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 18,979 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 19,289 shares (to pay taxes)
  8. 4 Shares withheld for taxes CEO gave up 2,255 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes CEO gave up 20,840 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes CEO gave up 782 shares (to pay taxes)
  19. 4 Open-market buy CEO bought 50,000 shares at $1.91 ($95,470)
  20. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 21,930 shares (to pay taxes)

Page 3 of 38 · 760 filings